KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Notes Payables (2018 - 2025)

Biogen (BIIB) has 13 years of Notes Payables data on record, last reported at $1.7 billion in Q1 2025.

  • For Q1 2025, Notes Payables fell 73.26% year-over-year to $1.7 billion; the TTM value through Mar 2025 reached $1.7 billion, down 73.26%, while the annual FY2024 figure was $1.7 billion, 1065.73% up from the prior year.
  • Notes Payables reached $1.7 billion in Q1 2025 per BIIB's latest filing, roughly flat from $1.7 billion in the prior quarter.
  • Across five years, Notes Payables topped out at $7.3 billion in Q2 2022 and bottomed at $150.0 million in Q4 2023.
  • Average Notes Payables over 5 years is $2.9 billion, with a median of $1.7 billion recorded in 2024.
  • Peak YoY movement for Notes Payables: crashed 97.61% in 2023, then soared 1065.73% in 2024.
  • A 5-year view of Notes Payables shows it stood at $999.1 million in 2021, then surged by 528.67% to $6.3 billion in 2022, then plummeted by 97.61% to $150.0 million in 2023, then skyrocketed by 1065.73% to $1.7 billion in 2024, then increased by 0.03% to $1.7 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Notes Payables were $1.7 billion in Q1 2025, $1.7 billion in Q4 2024, and $1.7 billion in Q3 2024.